Menopause changes your body.
EllieMD HRT Program helps you navigate it with precision.

Hormone Replacement Therapy replenishes the estrogen and progesterone the body stops producing during menopause. These hormones influence sleep, mood, body composition, bone density, cognitive function, cardiovascular health, and much more. When they decline, the effects are felt across nearly every system in the body. HRT is among the most extensively studied interventions in women's medicine, with decades of clinical evidence supporting its use for menopausal symptom management.

HRT may be a good fit for any woman experiencing menopause symptoms that are affecting quality of life, including hot flashes, night sweats, disrupted sleep, mood changes, cognitive difficulties, vaginal discomfort, low libido, joint pain, or changes in body composition. Women who are within 10 years of their last period and under 65 are generally considered strong candidates, though eligibility is always determined by a licensed provider based on your individual health history.

Every EllieMD HRT Program is built around your individual symptom profile and health history, so what you receive depends on what a licensed provider determines is clinically appropriate for you.

Each order is designed to cover an 8-week supply. EllieMD HRT Program is on subscription  for uninterrupted care. 

Medication eligibility and prescriptions are determined solely by licensed medical providers  based on clinical appropriateness. Not all individuals will qualify for treatment. Individual  results may vary.

Treatment plans are tailored based on your symptoms, medical history, and provider evaluation. Depending on your clinical profile, treatment may include a personalized combination of capsules and creams formulated to address your individual hormonal needs. 

Both deliver bioidentical estradiol systemically and are established methods used in hormone therapy. The cream absorbs through the skin directly into the bloodstream, bypassing first-pass liver metabolism. The capsule is taken orally and processed through the digestive system. Because transdermal delivery bypasses the liver, it may be associated with a more favorable cardiovascular and clotting profile. 

Medication eligibility and prescriptions are determined solely by licensed medical providers 

based on clinical appropriateness. 

At this time, EllieMD HRT Program is designed for women who have reached menopause or postmenopause, defined as 12 or more consecutive months without a menstrual period. We are actively working to expand our care to include perimenopausal support in the future.

If you're unsure where you are in the transition, please consult your primary care provider. If EllieMD HRT Program isn't the right fit for your current stage, we'll let you know during your medical assessment so you can pursue the care that's most appropriate for you.

This therapy may not be appropriate for everyone. Individuals with the following conditions should consult with their healthcare provider before use:

• Active cancer or undergoing cancer treatment 
• History of blood clots 
• Arterial thromboembolic disease (e.g. heart attack, stroke) 
• Severe liver impairment 
• Undiagnosed abnormal genital (vaginal) bleeding 
• Over 65 years of age

This list is not comprehensive. Additional medical conditions, medications, or individual  health factors may affect whether EllieMD HRT Program is appropriate. Eligibility is determined by a licensed healthcare provider based on a medical evaluation.

Potential side effects can vary depending on the treatment plan and formulation prescribed. These can include: 

• Breast tenderness
• Bloating
• Nausea
• Headaches
• Spotting
• Mood changes
• Skin irritation at the application site
• Changes in libido

Always consult with a medical professional before beginning any treatment program.

Labs are not required before beginning HRT. Leading menopause organizations, including ACOG, The Menopause Society, and NICE, support a symptom-based approach to diagnosing menopause. That said, baseline labs can be a meaningful part of your care. Many symptoms commonly associated with menopause can overlap with other conditions, and having a baseline on file can provide useful context down the road. Those who wish to pursue baseline labs are encouraged to do so through their primary care provider.

Bioidentical hormones are structurally identical to hormones naturally produced by the body. Synthetic or non-bioidentical hormone therapies may have different molecular structures and distinct clinical considerations. EllieMD’s Menopausal HRT Program includes bioidentical, micronized hormone and hormone precursor options, including estradiol, progesterone, DHEA, and pregnenolone.

Compounded medications are not FDA-approved. Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness.

Micronized means the active ingredient has been processed into very fine particles to help support absorption and consistency. In EllieMD’s HRT Program, estradiol, progesterone, DHEA, and pregnenolone are offered in micronized forms when clinically appropriate.

Yes. Even though your prescription is reviewed by a licensed provider, you should inform your primary care physician that you are using HRT. Your primary care provider has a comprehensive understanding of your medical history and can help ensure coordinated, safe 

care.